calendar
3,497 catalysts · 3,243 8k filing · 559 earnings · 108 phase 2 completion · 50 phase 1 completion · 28 phase 1 2 completion · 22 phase 1 initiation
3,497 catalysts · 3,243 8k filing · 559 earnings · 108 phase 2 completion · 50 phase 1 completion · 28 phase 1 2 completion · 22 phase 1 initiation
Items: 5.03, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 1.01, 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 1.01, 3.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 9.01
Items: 1.01, 2.03, 9.01
Items: 8.01
Items: 1.01, 2.03, 3.02, 9.01
Items: 1.01, 9.01
Items: 1.01, 3.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 5.07
Items: 1.01, 5.08, 9.01
Items: 8.01, 9.01
Items: 5.02
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 8.01, 9.01
Items: 1.01, 2.03, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 2.02, 9.01